Neuland Laboratories Ltd
NEULANDLAB
Company Profile
Business description
Neuland Laboratories Ltd is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The group has only one reportable segment manufacture of active pharmaceutical ingredients and allied services. It has presence in India, Europe, USA and North America, and Rest of the world.
Contact
Road Number 82, Jubilee Hills
Plot No. 573A-III, Phoenix IVY Building, 11th Floor-5th Office Level
HyderabadTG500033
INDT: +91 4067611600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
3,881
Stocks News & Analysis
stocks
ASX share undervalued despite margin woes
Short term margin pressure yet shares remain undervalued on improved outlook.
stocks
A better way to predict long-term stock returns
A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks
Five star stock added to August best ideas list
Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,849.30 | 74.60 | -0.84% |
| CAC 40 | 8,104.33 | 13.45 | -0.17% |
| DAX 40 | 25,454.79 | 13.98 | 0.05% |
| Dow JONES (US) | 52,421.20 | 152.09 | -0.29% |
| FTSE 100 | 10,667.99 | 29.58 | -0.28% |
| HKSE | 24,667.24 | 250.36 | -1.00% |
| NASDAQ | 26,186.41 | 146.62 | -0.56% |
| Nikkei 225 | 63,484.10 | 8.89 | -0.01% |
| NZX 50 Index | 13,484.22 | 76.47 | -0.56% |
| S&P 500 | 7,619.98 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,672.50 | 77.40 | -0.88% |
| SSE Composite Index | 3,864.28 | 21.05 | -0.54% |